PHARMAXIS LTD (PXS.AX)
From ValueWiki
Business Description from asx.com.au: The company is a specialist pharmaceutical company committed to the research, development and commercialisation of human therapeutic products for chronic respiratory and autoimmune diseases and the development of an improved lung function test.[1]
|
|
Company Analysis
You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.
The edit window has shortcut and help links if you need them.[2] Be bold!
News Feed
Leadership
- PHARMAXIS LTD Executive Information
- PHARMAXIS LTD Directors / Senior Management[1]
Mr Denis Hanley (Independent Director, Chairman) Dr Alan Robertson (Director, CEO) Mr David McGarvey (CFO) Dr John Villiger (Director) Mr Charles Kiefel (Independent Director) Mr Malcolm McComas (Independent Director) Mr Peter Farrell (Independent Director)
Risks
This section needs content! Click the blue edit link (to the right) to contribute.
Research Links
- PHARMAXIS LTD Profile
- PHARMAXIS LTD Fundamentals
- PHARMAXIS LTD Technical Analysis
- PHARMAXIS LTD Contact Information[1]
- Website: http://www.pharmaxis.com.au/
- Address: Unit 2 , 10 Rodborough Road , FRENCHS FOREST , NSW, AUSTRALIA, 2086
- Phone: (02) 9454 7200
- Fax: (02) 9451 3622
- Share Registry: COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 3 , 60 CARRINGTON STREET , SYDNEY , NSW, AUSTRALIA, 2000
- Share Registry Phone: 1300 787 272 (BKR ONLY)
- PHARMAXIS LTD Message Boards
Notes
- ↑ 1.0 1.1 1.2 http://www.asx.com.au/asx/research/CompanyInfoSearchResults.jsp?searchBy=asxCode&allinfo=on&asxCode=PXS ASX.com.au
- ↑ This is a sample reference.
